Previous 10 | Next 10 |
Second-quarter revenue of $3.75 billion increased 21% on a reported basis, 26% on a constant currency basis and 3% on an operational basis 1 Second-quarter U.S. GAAP earnings per share (EPS) totaled $0.50; Adjusted EPS totaled $0.87 Baxter now expects full-year 2022 sales ...
We believe the healthcare sector's strong growth momentum with average revenue growth of 3.8% QoQ indicates a positive outlook, with the equipment industry forecasted at a market CAGR of 5.5%. For the healthcare equipment industry, we believe the outlook is supported by the average gu...
Baxter ( NYSE: BAX ) is scheduled to announce Q2 earnings results on Thursday, July 28th, before market open. EPS Estimate is $0.87 (+8.7% Y/Y) and the consensus Revenue Estimate is $3.88B (+25.2% Y/Y). has beaten EPS estimates 100% of the time and has beaten revenue estim...
Although the healthcare sector has largely resisted this year's downward pressure, it is likely to succumb as pressure increases. Healthcare stocks have a well-deserved reputation for cyclical defense, but they are more likely to underperform in "secular" bear markets. Healthcare ...
Baxter’s 8.7% 5-yr return on invested capital, ROIC, is quite a bit below its peers. TTM ROIC of 6.1% is about half the Industry ETF avg of 11.1%. Long-term debt ballooned from $5.8 billion at the end of 2020 to $17.1 billion as of March 2022. Goodwill assets also jumped t...
Baxter ( NYSE: BAX ) declares $0.29/share quarterly dividend , in line with previous. Forward yield 1.79% Payable Oct. 3; for shareholders of record Sept. 2; ex-div Sept. 1. See BAX Dividend Scorecard, Yield Chart, & Dividend Growth. For further details s...
BAXTER DETAILS PROGRESS TOWARD ENVIRONMENTAL, SOCIAL AND GOVERNANCE (ESG) PRIORITIES IN ANNUAL CORPORATE RESPONSIBILITY REPORT Canada NewsWire Provides updates across 2030 Corporate Responsibility Commitment and Goals Unveils Climate Action Roadmap describing...
Provides updates across 2030 Corporate Responsibility Commitment and Goals Unveils Climate Action Roadmap describing how Baxter plans to achieve its goal to become carbon neutral for its direct operations by 2040 Highlights $52 million contributed in cash and products from Bax...
A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends. Companies with upcoming ex-dividend dates. Companies with upcoming pay dates. For further details see: Dividend Champion, Contender, An...
Baxter International (NYSE:BAX) is trading lower in the pre-market Friday on below-average volume after Wells Fargo downgraded the health equipment maker to Equal Weight from Overweight, noting pressure on the near-term outlook. In addition to a potential downside to sales and earnings in 2Q ...
News, Short Squeeze, Breakout and More Instantly...
Baxter International Inc. Company Name:
BAX Stock Symbol:
NYSE Market:
Baxter International Inc. Website:
Five new launches reinforce Baxter’s focus on differentiated products and enhance the company’s Pharmaceuticals portfolio in critical therapeutic areas Products feature ready-to-use formulations to help support patient safety and offer added convenience for healthcare profession...
Baxter International Inc. (NYSE:BAX), a global medtech leader, will host a conference call to discuss its first-quarter 2024 financial results on Thursday, May 2, 2024 at 7:30 a.m. Central Time. To participate in this conference call please follow this link https://registrations.events/direct/Q...